Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseSuspended |
First Approval Ctry. / Loc.- |
First Approval Date- |
评价经舒颗粒治疗原发性痛经有效性和安全性的随机、双盲、单模拟、安慰剂平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, single-dummy, placebo-controlled, multicenter phase II clinical trial to evaluate the efficacy and safety of Jingshu Granule in the treatment of primary dysmenorrhea
评价经舒颗粒治疗原发性痛经气滞血瘀证的有效性和安全性
[Translation] To evaluate the efficacy and safety of Jingshu granules in the treatment of primary dysmenorrhea with qi stagnation and blood stasis syndrome
100 Clinical Results associated with Shandong Haihui Bioengineering Co., Ltd.
0 Patents (Medical) associated with Shandong Haihui Bioengineering Co., Ltd.
100 Deals associated with Shandong Haihui Bioengineering Co., Ltd.
100 Translational Medicine associated with Shandong Haihui Bioengineering Co., Ltd.